305 related articles for article (PubMed ID: 14724308)
1. Antiplatelet therapy for ischemic heart disease.
Lange RA; Hillis LD
N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308
[No Abstract] [Full Text] [Related]
2. Contemporary use of antiplatelet therapies in percutaneous coronary interventions.
Saw J; Moliterno DJ
Coron Artery Dis; 2003 Aug; 14(5):373-80. PubMed ID: 12878902
[No Abstract] [Full Text] [Related]
3. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
Mehta SR;
J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860
[TBL] [Abstract][Full Text] [Related]
4. Focus on adjunctive pharmacotherapy to improve outcomes of percutaneous coronary intervention.
Kereiakes DJ
J Invasive Cardiol; 2009 Mar; 21(3):110-3. PubMed ID: 19258641
[No Abstract] [Full Text] [Related]
5. [Therapy of acute coronary syndrome with glycoprotein IIb/IIIa antagonists].
Araujo R; Agustí A
Med Clin (Barc); 2000 Oct; 115(11):435-7. PubMed ID: 11093849
[No Abstract] [Full Text] [Related]
6. New antiplatelet agents.
White HD; French JK; Ellis CJ
Aust N Z J Med; 1998 Aug; 28(4):558-64. PubMed ID: 9777140
[TBL] [Abstract][Full Text] [Related]
7. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
EPISTENT Investigators
Lancet; 1998 Jul; 352(9122):87-92. PubMed ID: 9672272
[TBL] [Abstract][Full Text] [Related]
8. [Glycoprotein IIb/IIIa antagonists].
Hennemann A
Med Monatsschr Pharm; 2000 Dec; 23(12):385-90. PubMed ID: 11147193
[No Abstract] [Full Text] [Related]
9. Optimization of platelet therapy.
Fry JA; Grines CL
Semin Interv Cardiol; 2000 Sep; 5(3):117-28. PubMed ID: 11054909
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic therapy in cardiac stent patients.
Cannan CR
Curr Cardiol Rep; 2001 Jan; 3(1):78-84. PubMed ID: 11139803
[TBL] [Abstract][Full Text] [Related]
11. Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban).
Assali AR; Salloum J; Sdringola S; Moustapha A; Ghani M; Hale S; Schroth G; Fujise K; Anderson HV; Smalling RW; Rosales OR
Am J Cardiol; 2001 Oct; 88(8):884-6, A6. PubMed ID: 11676953
[No Abstract] [Full Text] [Related]
12. Platelet glycoprotein IIb/IIIa receptor blockade after coronary angioplasty.
Khan SS; Forrester J
N Engl J Med; 1997 Oct; 337(17):1243; author reply 1244-5. PubMed ID: 9340527
[No Abstract] [Full Text] [Related]
13. Optimizing antiplatelet therapy in coronary interventions.
King SB
Clin Cardiol; 2000 Nov; 23 Suppl 6(Suppl 6):VI-8-13. PubMed ID: 11129685
[TBL] [Abstract][Full Text] [Related]
14. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitors of platelet glycoprotein IIb-IIIa in cardiology].
Obradović S; Gligić B; Djordjević D; Jovicić A; Romanović R; Ratković N; Dincić D; Orozović V; Nikolić G
Vojnosanit Pregl; 2001; 58(1):65-72. PubMed ID: 11419288
[No Abstract] [Full Text] [Related]
16. [Antiplatelet therapy].
Ikeda Y
Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1802-11. PubMed ID: 10581767
[No Abstract] [Full Text] [Related]
17. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
Popma JJ; Satler LF
J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes.
Boersma E
J Am Coll Cardiol; 2007 Jan; 49(2):276; author reply 277. PubMed ID: 17222743
[No Abstract] [Full Text] [Related]
19. Clopidogrel treatment prior to percutaneous coronary intervention: when enough isn't enough.
Steinhubl SR; Charnigo R
JAMA; 2006 Apr; 295(13):1581-2. PubMed ID: 16533936
[No Abstract] [Full Text] [Related]
20. The platelet, the patient, and periprocedural infarction during percutaneous transluminal coronary angioplasty.
Fischman DL; Savage MP
JAMA; 1997 Aug; 278(6):518-9. PubMed ID: 9256229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
